产品名称 | NebuSelect™ Recombinant Human EPHA5, His-tag |
---|---|
目录号 | NBL-240871 |
别名 | EPHA5; EHK-1; EK7; BSK; EHK1; HEK7; TYRO4; EphA5; Rek7; TYRO4HEK7CEK7 |
外观 | see COA |
分子量 | Ala26-Pro573 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | P54756-1 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-240871-100ug | 100ug | Inquire | Inquire | |
NBL-240871-1mg | 1mg | Inquire | Inquire | |
NBL-240871-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human EPHA5, His-tag
Catalog#:
NBL-240871
Description:
NebuSelect™ Recombinant Human EPHA5, His-tag(Cat#NBL-240871) is expressed in HEK293 with His tag at the C-Terminus.It contains Ala26-Pro573.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 61.9 kDa. Due to glycosylation, the protein migrates to 68-80 kDa based on Bis-Tris PAGE result.
Target Name:
EPHA5; EHK-1; EK7; BSK; EHK1; HEK7; TYRO4; EphA5; Rek7; TYRO4HEK7CEK7
Target Information:
Ephrin type-A receptor 5 (EphA5) expression was detected in all non-tumor gastric epithelia but was differentially expressed among gastric cancer samples. EphA5 is differentially expressed in gastric cancer. EphA5 may therefore be a potential therapeutic target and may have clinical utility as a marker for lymph node metastasis in gastric cancer.
Amino Acid Sequence:
Ala26-Pro573
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.